CD86 and Alzheimer disease: In line with existing literature, our study confirmed that AD model rats exhibit a marked microglial polarization imbalance, characterized by an upregulation of M1 markers (CD86, iNOS) and a concomitant downregulation of M2 markers (CD206, Arg-1).